Atlas Trials

The Effects of Neprilysin on Glucagon-like Peptide-1

Clinical trial NCT03717688 · COMPLETED

Trial details

NCT number
NCT03717688
Sponsor
Nicolai Jacob Wewer Albrechtsen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesHeart Failure
Start date
2018-05-17
Primary completion
2019-02-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.